Diplomat Pharmacy (DPLO) Misses Q1 EPS by 26c, Revenues Beat; Offers FY19 EPS Views Below Consensus, FY19 Revenue Mid-Point Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Diplomat Pharmacy (DPLO) Misses Q1 EPS by 26c, Revenues Beat; Offers FY19 EPS Views Below Consensus, FY19 Revenue Mid-Point Guidance Above Consensus

Diplomat Pharmacy (DPLO) Appoints Dave Loschinskey as COO

May 6, 2019 4:30 PM EDT

Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the company's board of directors has appointed Dave Loschinskey to serve as chief operating officer effective May 2. In addition, Gary Rice will retire from his position as executive vice president of operations effective May 17, 2019.

Brian Griffin, Diplomat's chairman and CEO expressed his gratitude to Gary Rice: "I want to thank Gary for his significant contributions to Diplomat in his 8 years at the company. Gary has been instrumental in the company's growth during his tenure and we wish him all the best in his future... More